Navigation Links
Nektar Therapeutics Reports Third Quarter 2009 Financial Results
Date:11/4/2009

- --- ---- --- Net loss $(30,967) $(37,038) $(94,843) $(111,118) ======== ======== ======== ========= Basic and diluted net loss per share $(0.33) $(0.40) $(1.02) $(1.20) Shares used in computing basic and diluted net loss per share 92,789 92,425 92,621 92,413 NEKTAR THERAPEUTICS CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (unaudited) ASSETS September 30, 2009 December 31, 2008 (1) ------------------ ----------------- Current assets: Cash and cash equivalents $32,777 $155,584 Short-term investments 242,901 223,410 Accounts receivable, net of allowance 6,330 11,161 Inventory 8,930 9,319 Other current assets 7,275 6,746 ----- ----- Total current assets $298,213 $406,220 Property and equipment, net 74,624 73,578 Goodwill 76,501 76,501 Other assets 3,313 4,237 ----- ----- Total assets $452,651 $560,536 ======== ======== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $6,397 $13,832 Accrued compensation 9,711 11,570 Accrued clinical trial expens
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Host Conference Call to Discuss Todays Announcement of a New Partnership for NKTR-118 and NKTR-119
3. AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
4. Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
5. Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets
6. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
7. Nektar Therapeutics Reports First Quarter 2009 Financial Results
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
9. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
10. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
11. Nektar Announces Retirement of Irwin Lerner from Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Look inside the new Preferred ... the lab, from fluid handling to instruments to supplies. ... when you order. , Preferred Solutions features a ... the L/S® model for precise flow control and dispensing ...
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 This ... on nonclinical and clinical safety assessment in biosimilars. , ... path for biosimilar drug development, however the complex nature ... to quality, safety and efficacy extremely challenging. Based on ...
(Date:1/15/2014)... Rochester, NY (PRWEB) January 15, 2014 The ... cause a major disease. One of these latent viruses is ... is rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... the theory, a study found that RA patients have high ...
(Date:1/15/2014)... Toronto, ON (PRWEB) January 15, 2014 ... an experimental new therapy for the treatment of tinnitus. ... unique tinnitus frequency, and over a period of weeks to ... Notched Sound Therapy in two forms: Notched Music and Notched ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... SAN FRANCISCO, Calif., Aug. 27 Poniard,Pharmaceuticals, Inc. ... oncology, today announced that Jerry McMahon, Ph.D., chairman ... September during which he,will provide a corporate overview, ... picoplatin, the Company,s lead product candidate., -- ...
... and MILPITAS, California, August 27, Peakdale Molecular ... chemistry services to the pharmaceutical and,biotechnology industry, ... unique,and cost-effective provider of products and systems ... of AssayReady4U(TM)., AssayReady4U(TM) is an online ...
... INDIANAPOLIS, Aug. 26 Amylin,Pharmaceuticals, Inc. (Nasdaq: AMLN ... ),in a conference call today provided context and additional ... Administration (FDA),update to a prior alert for BYETTA(R) (exenatide) ... cases referenced,in the alert, as well as others, and ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Upcoming Conference Participation 2Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC 2Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC 3Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 2Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 3Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 4Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 5Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 6
(Date:4/17/2014)... KAN. A Kansas State University engineer has ... and remotely detects improvised explosive devices. The same ... William Dunn, the Steven M. and Kay L. ... mechanical and nuclear engineering, and his research team ... hidden underground or in car trunks. The distance ...
(Date:4/17/2014)... professor Rajendra Singh Thursday as a "Champion of ... solar deployment in the residential, commercial and industrial ... of Electrical and Computer Engineering and director of ... local hero leading the charge across the country ... power and driving policy changes at the local ...
(Date:4/17/2014)... the Amazon help create tinderbox conditions for wildfires ... forest loss during drought years, according to a ... in the Amazon could reach a "tipping point" ... to large-scale loss of trees, making recovery more ... Penn State. , "We documented one of the ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2White House honors Clemson professor as 'Champion of Change' for solar deployment 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 3
... could also be giving us bad breath, according to research ... Medical Microbiology . For the first time, scientists have found ... who are not showing signs of stomach disease. The ... some of which can cause disease. Helicobacter pylori ...
... set of proteins known as cannabinoid receptors, which ... body also has chemicals known as endocannabinoids that ... (AEA) and 2-arachidonoylglycerol (2-AG). These natural components of ... efforts to develop new treatments not only for ...
... Buenos Aires, Argentina Current research suggests that melatonin ... disease. The related report by Sande et al., "Therapeutic ... December issue of The American Journal of Pathology ... pain in their eyes, and their vision rapidly deteriorates. ...
Cached Biology News:Stomach ulcer bug causes bad breath 2Scripps research team defines new painkilling chemical pathway 2Melatonin may save eyesight in inflammatory disease 2
Chicken polyclonal to ADI1 ( Abpromise for all tested applications). Antigen: Full length native protein (purified), corresponding to amino acids 1-179 of Human ADI1. Entrez GeneID: 55256 ...
anti-JNK2 Immunogen: Recombinant human JNK2 protein Accession Number: NM_002752 Quality Assurance: Routinely evaluated by immunoblot. Molecular Weight: 46 and/or 54 kDa Available ...
Gloves are 9.25 long, latex, powder free, smooth and ambidextrous....
Request Info...
Biology Products: